title: Immune supplementation and immune modulation with intravenous immunoglobulin.
authors.affiliation: Meakins Christie Laboratories, McGill University, Montreal, Canada.
authors.forename: Bruce D
authors.initials: BD
authors.lastname: Mazer
authors.forename: Salem
authors.initials: S
authors.lastname: Al-Tamemi
authors.forename: Joyce W
authors.initials: JW
authors.lastname: Yu
authors.forename: Qutayba
authors.initials: Q
authors.lastname: Hamid
mesh_terms: D004062:DiGeorge Syndrome / Q000628:therapy; D020275:Guillain-Barre Syndrome / Q000276:immunology / Q000628:therapy; D006801:Humans; D006969:Hypersensitivity, Immediate / Q000276:immunology / Q000628:therapy; D016756:Immunoglobulins, Intravenous / Q000008:administration & dosage / Q000627:therapeutic use*; D007153:Immunologic Deficiency Syndromes / Q000276:immunology / Q000473:pathology / Q000628:therapy; D009080:Mucocutaneous Lymph Node Syndrome / Q000276:immunology / Q000473:pathology / Q000628:therapy; D016553:Purpura, Thrombocytopenic, Idiopathic / Q000276:immunology / Q000473:pathology / Q000628:therapy
chemical_list: D016756:Immunoglobulins, Intravenous